Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vancomycin × Classical hematology × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1 Classical hematology 1 Breast 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

Cyclophosphamide 4 fludarabine phosphate 3 fludarabine 3 Mycophenolic Acid 3 Biopsy 3 Azacitidine 3 venetoclax 2 thymoglobulin 2 apixaban 2 Whole-Body Irradiation 2 Vorinostat 2 Tacrolimus 2 Specimen Handling 2 Rituximab 2 Melphalan 2 Lenalidomide 2 Injections 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Decitabine 2 Busulfan 2 ravulizumab 1 oprelvekin 1 hetrombopag 1 decitabine and cedazuridine drug combination 1 cedazuridine 1 Vancomycin 1 Transplantation 1 Tazobactam 1 TAK-243 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948463 2026-03-20

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡